https://www.selleckchem.com/ALK.html
3% versus 46.7%, = 0.01). Also, primary nonfunction rates were lower in the cDCD using NRP group (4.5% versus 6.4% cDCD-RR and 10.2% DBD). Patient survival rates were 90% in all groups. No differences were found in graft survival rates at 1 y. The use of abdominal NRP improves early function recovery of KT from cDCD, making their outcomes comparable with those of DBD. The use of abdominal NRP improves early function recovery of KT from cDCD, making their outcomes comparable with those of DBD.In the era of antibiotic resistance, in silico predic
Beğen
Yorum Yap
Paylaş
